EU Regulators Seek Information on Products Tested by GVK Bio Following Inspection Concerns

Drug Industry Daily
European regulators are asking drugmakers to submit information on products that were part of bioequivalence trials conducted at contract research organization GVK Biosciences’ India facility, after an inspection raised serious concerns about good clinical practice compliance.

To View This Article:


Subscribe To Drug Industry Daily